RecruitingNCT07401797

Specimens for Lung Cancer Panel Design

Sponsor

Maverix Medical

Enrollment

2,000 participants

Start Date

Aug 7, 2024

Study Type

OBSERVATIONAL

Conditions

Lung Nodules

Summary

This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood samples and medical data from people who have a suspicious spot (nodule) found on their lungs. The goal is to develop a blood test that can help doctors figure out if a lung nodule is cancerous without needing a biopsy. **You may be eligible if...** - You have at least one indeterminate lung nodule (5mm or larger) with moderate risk of cancer (greater than 5% by a standard calculator) - Your doctor plans to follow up with a biopsy, PET scan, or active monitoring within the next 7 months - You are able to donate approximately 40 mL of blood (about 3 tablespoons) **You may NOT be eligible if...** - Your nodule has a very high risk of cancer (greater than 50% by the standard calculator), which would typically require immediate action Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.